Strategic Advisory Board

The Bionow Strategic Advisory Board is composed of senior individuals from across the North of England representing a cross-section of our membership and the sector as a whole. The Advisory Board advises Bionow offering sector relevant strategic advice and guidance.

The current membership of the Strategic Advisory Board is as follows:

  • Chair: Mike Snowden, VP and Head of Discovery Science, AstraZeneca
  • Graham Bond, Partner, RSM
  • Allan Brown, Chief Operating Officer, QuantuMDx
  • Linda Randall, Director, Process Sciences, Allergan Biologics
  • Malcolm Jackson, Head of Institute, Institute of Ageing and Chronic Disease, University of Liverpool
  • Chris Doherty, Alderley Park Site Director, MSP
  • Paul Found, COO, Fujifilm Diosynth Biotechnologies
  • John Goodacre, Faculty of Health and Medicine, Lancaster University
  • Andy Gover, General Manager, Head of R&D, QIAGEN
  • Catherine Headley, Head of Strategic Accounts, University of Manchester
  • Andy Jones, Founder and Director, MedrusPharma Consulting
  • Neil Murray, CEO, NDM Biotech
  • Lloyd Payne, Executive Vice President, Evotec
  • Dave Simpson, CEO, Glythera
  • Joe de Sousa, Director Science and Technology, AstraZeneca
  • John Stageman, Chair, Bionow
  • Jane Theaker, Associate, Core Precision
  • Simon Wallwork, Partner, Slater Heelis

 

Our Valued Sponsors & Partners